unknown
Stage
1
Investors
About
Biocogniv develops AI-based diagnostic tools that analyze routine laboratory data to detect and predict acute medical conditions such as sepsis earlier than standard care, helping hospitals reduce preventable deaths and costs.
Explore Biocogniv's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.